XRP Healthcare’s Strategic Leap: Inside Our Public Listing Deal with AAJ and ARC Group

We’re thrilled to share a major milestone: XRP Healthcare M&A Holding Inc. has officially signed a Definitive Agreement with AAJ Capital 3 Corp., with the esteemed ARC Group as our exclusive financial advisor.

If you’re not fluent in the language of capital markets, terms like RTO, CPC, TSXV, and Definitive Agreement can feel like alphabet soup. But don’t worry—here’s a clear, jargon-free breakdown of what this means and why it matters.

Taking a Smarter Path to the Public Markets

When companies decide to “go public,” most people think of an IPO (Initial Public Offering)—a well-known route where shares are sold on a stock exchange for the first time.

But there’s another route that’s faster and more flexible: a Reverse Takeover (RTO). That’s the route XRP Healthcare M&A Holding Inc. is taking.

What’s a Reverse Takeover (RTO), and How Does It Work?

Instead of launching an IPO from scratch, an RTO lets a private company merge with a public one—in this case, AAJ Capital 3 Corp., a Capital Pool Company (CPC) listed on the TSX Venture Exchange (TSXV) under the symbol AAAJ.P.

Through this process, XRP Healthcare M&A Holding Inc. becomes the new public entity. The current listing (AAAJ.P) will be phased out, replaced by our new name and a fresh ticker symbol on the TSXV.

This process is officially called a Qualifying Transaction (QT) under TSXV regulations. It’s designed to help high-growth companies—like ours—access public markets without the lengthy and costly process of a traditional IPO.

What Does the “Definitive Agreement” Mean?

This isn’t just a handshake—it’s the legally binding contract that sets everything in motion. The Definitive Agreement outlines exactly how the merger will work, from share exchanges to legal requirements for closing the deal.

In simpler terms: both sides have agreed to move forward, subject to regulatory approvals.

Why ARC Group’s Involvement Is Crucial

ARC Group brings world-class financial expertise to the table. Known for handling high-level international M&A and listing deals, ARC is guiding us across multiple jurisdictions—including Canada, the UAE, and East Africa.

Their involvement ensures this transaction is conducted to the highest global standards and adds major credibility to every step of the process.

Why This Move Matters for XRP Healthcare

This isn’t just a corporate maneuver—it’s a strategic leap toward transforming healthcare access across Africa and other emerging markets.

We’ve already begun acquiring pharmacies in Uganda, and our XRPH AI-powered multilingual app is live—connecting users with healthcare insights, prescription tools, and localized support in multiple languages.

By going public, we unlock new opportunities:

• Greater visibility and trust

• Access to institutional funding

• Scalability of our AI and M&A model

This means faster rollouts, wider impact, and deeper integration with the communities we aim to serve.

What Comes Next?

With the Definitive Agreement signed, here’s what to expect:

• Regulatory submission of the deal to the TSXV

• Final approvals and compliance checks

• Trading begins under the new XRP Healthcare M&A Holding Inc. name

• Continued expansion of our AI platform and pharmacy acquisition roadmap

More Than a Business Move—It’s a Movement

This journey isn’t just about listing shares. It’s about proving that a company with roots in London, operations in Dubai, and a vision for Africa can meet the highest standards of international capital markets.

It’s about connecting innovation to impact, and capital to communities.

We’re honored to partner with ARC Group and AAJ Capital 3 Corp. in this endeavor—and even more energized by what it means for the future of health access across the globe.

The path to public trading is now paved—and this is just the beginning.